Apoptosis participates to liver damage in HSV-induced fulminant hepatitis

被引:20
作者
Prétet, JL
Pelletier, L
Bernard, B
Coumes-Marquet, S
Kantelip, B
Mougin, C
机构
[1] CHU Jean Minjoz, Biol Cellulaire & Mol Lab, F-25030 Besancon, France
[2] Inst Etud & Transfert Genes, F-25030 Besancon, France
[3] CHU Jean Minjoz, Anat Pathol Lab, F-25030 Besancon, France
关键词
hepatitis; herpes simplex virus; liver; programmed cell death;
D O I
10.1023/A:1026156130656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Background: HSV fulminant hepatitis is a rare pathology. Rapid hepatic failure, as a consequence of extended liver damage, has generally been attributed to necrosis. As apoptosis can constitute another way for hepatocytes to die, we decided to investigate whether programmed cell death took place during HSV fulminant hepatitis. Methods: Liver sections were obtained from two cases of fulminant herpetic hepatitis as well as from hepatitis B virus and Rickettsia-infected livers. Herpes simplex virus infection was confirmed using in situ hybridization. Apoptosis was assessed by histopathological examination, p53, activated-caspase 3 and Fas immunohistochemistry and TUNEL labeling. Results: We report that the number of cells expressing activated-caspase 3 was largely increased in fulminant herpes simplex virus hepatitis, when compared to livers chronically infected by hepatitis B virus or from a Rickettsial acute hepatitis. Apoptosis of hepatocytes was confirmed by a positive double-staining for activated-caspase 3 and hepatocytes. Finally, the apoptotic process has progressed beyond the step of nuclear DNA cleavage as demonstrated by TUNEL labeling. Conclusion: These data as a whole show that apoptosis is responsible, at least partially, for liver damage during HSV fulminant hepatitis.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 44 条
[1]
MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[2]
ANURAS S, 1976, GASTROENTEROLOGY, V70, P425
[3]
Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1 [J].
Aubert, M ;
O'toole, J ;
Blaho, JA .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10359-10370
[4]
Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle [J].
Bernard, B ;
Fest, T ;
Prétet, JL ;
Mougin, C .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (03) :234-244
[5]
VIRAL COINFECTIONS IN HUMAN PAPILLOMAVIRUS-ASSOCIATED ANOGENITAL LESIONS ACCORDING TO THE SEROSTATUS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BERNARD, C ;
MOUGIN, C ;
MADOZ, L ;
DROBACHEFF, C ;
VANLANDUYT, H ;
LAURENT, R ;
LAB, M .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :731-737
[6]
Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? [J].
Bertoletti, A ;
Maini, MK .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :403-408
[7]
CHASE RA, 1987, REV INFECT DIS, V9, P329
[8]
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50
[9]
Caspases disrupt the nuclear-cytoplasmic barrier [J].
Faleiro, L ;
Lazebnik, Y .
JOURNAL OF CELL BIOLOGY, 2000, 151 (05) :951-959
[10]
Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: Report of two cases and review of the literature [J].
Farr, RW ;
Short, S ;
Weissman, D .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1191-1194